WAVRE, Belgium — 24 April 2025: iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announces positive five-year data from the STAR-GLOBAL trial for the ...
(RTTNews) - AbbVie (ABBV) on Wednesday said it signed an alliance with iSTAR Medical SA, a Belgian medtech firm, to further develop and commercialize iSTAR's MINIject, a minimally invasive glaucoma ...
WAVRE, Belgium, July 10, 2019 /PRNewswire/ -- iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month ...
-- Five-year safety profile including corneal health confirmed and 38% IOP reduction sustained -- Over 5000 patients benefiting from limited commercial rollout of MINIject(R) worldwide to-date -- ...
STAR-GLOBAL is an extension trial of the initial EU clinical trials investigating the long-term safety and efficacy of MINIject ® in patients with up to five-years of follow-up. Patients implanted ...
Five-year safety profile including corneal health confirmed and 38% IOP reduction sustained Over 5000 patients benefiting from limited commercial rollout of MINIject ® worldwide to-date iSTAR Medical ...
iSTAR Medical's MINIject ® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health confirmed and 38% IOP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results